Vascular access placement in patients with incident CKD stage 4 and 5 attending an inner city nephrology clinic: A cohort study and survey of providers

4^th International Conference on Nephrology & Therapeutics

September 14-16, 2015 Baltimore, USA

Narender Goel1,2

1Middletown Medical PC, USA 2Orange Regional Medical Center, USA

Scientific Tracks Abstracts: J Nephrol Ther

Abstract :

The majority of incident hemodialysis (HD) patients initiate dialysis via catheters. We sought to identify factors associated with initiating hemodialysis with a functioning AV access. We conducted a retrospective chart review of all adult patients, age >18 years seeing a nephrologist with a diagnosis of CKD stage 4 or 5 during the study period between 06/01/2011 and 08/31/2012 and conducted a survey of providers about the process. The 221 patients (56% female) in the study had median age of 66 years (IQR, 57- 75) and were followed for a median of 1.26 years (IQR 0.6-1.68). By the end of study, 48 patients had initiated dialysis. Thirty-four of the patients started dialysis with a catheter (1 failed and 10 maturing AVFs), 9 with an AVF and 5 with an AVG. During the study period, 61 total AV accesses were placed (54 AVF and 7 AVG). A higher urinary protein/creatinine ratio and a lower eGFR at study entry were associated with AV access placement and dialysis initiation. A greater number of nephrology visits were associated with AV access creation but not with the initiation of dialysis. Hospitalizations and hospitalizations with an episode of acute kidney injury were strongly associated with dialysis initiation (odds ratio (OR) 13.0 (95% confidence interval (CI) 2.3 to 73.3, p-value=0.004) and OR 6.6 (95% CI 1.9 to 22.8, p-value=0.003)). Nephrologists may not be referring the correct patients to get an AV access surgery. A hospitalization with AKI is strongly associated with the need for dialysis in patients with stage 4 and 5 CKD.

Biography :

Narender Goel has completed his Nephrology Fellowship from Montefiore Medical Center & Albert Einstein College of Medicine, NY. He is presently working as a Nephrologist and Clinical Hypertension Specialist at Middletown Medical PC and Orange Regional Medical Center, NY. He is also an Adjunct Clinical Assistant Professor of Internal Medicine and Nephrology at Touro College of Osteopathic Medicine, New York, NY. He is also a Founder of Non-Profit Nephrology global website. His primary interests include mineral bone disorder, electrolytes, hypertension and vascular access.

Email: drnarendergoel@gmail.com